Opiant Pharmaceuticals, Inc.
OPNT · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $35 | $40 | $48 | $38 |
| Short-Term Investments | $0 | $0 | $3 | $15 |
| Receivables | $0 | $4 | $4 | $13 |
| Inventory | $0 | $0 | $0 | -$2,960 |
| Other Curr. Assets | $3 | $4 | $4 | $2,963 |
| Total Curr. Assets | $39 | $48 | $59 | $69 |
| Property Plant & Equip (Net) | $3 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $42 | $49 | $60 | $70 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $5 | $3 |
| Short-Term Debt | $2 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $2 | $2 | $1 | $3 |
| Total Curr. Liab. | $7 | $5 | $7 | $7 |
| LT Debt | $14 | $14 | $14 | $17 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $14 | $14 | $14 | $17 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $21 | $19 | $21 | $24 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$96 | -$86 | -$74 | -$62 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $116 | $115 | $113 | $109 |
| Total Equity | $21 | $30 | $39 | $47 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $42 | $49 | $60 | $70 |
| Net Debt | -$19 | -$26 | -$34 | -$21 |